Literature DB >> 11137538

Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.

G León1, M Monge, E Rojas, B Lomonte, J M Gutiérrez.   

Abstract

Whole IgG and F(ab')(2) equine-derived polyvalent (Crotalinae) antivenoms, prepared from the same batch of hyperimmune plasma, were compared in terms of neutralization of the lethal and defibrinating activities induced by Bothrops asper venom, their ability to reach the muscle tissue compartment in envenomated mice, and their potential for the induction of adverse reactions. Both preparations were adjusted to the same potency against the lethal effect of B. asper venom in experiments involving preincubation of venom and antivenom. Then, "rescue" experiments were performed, i.e. antivenom was administered either intravenously or intramuscularly at various times after envenomation. IgG and F(ab')(2) antivenoms were equally effective in the neutralization of lethality, both being more effective when administered i.v. than after i.m. injection. Neutralization decreased as the time lapse between envenomation and treatment increased. No significant differences were observed in the ability of antivenoms to neutralize defibrinating activity of B. asper venom in experiments involving independent injection of venom and antivenoms. There was a much higher accumulation of equine antibodies in muscle tissue that had been injected with B. asper venom than in non-envenomated tissue, indicating that venom-induced microvessel damage probably favors a prominent and similar extravasation of both IgG and F(ab')(2) antibodies. This may explain the similar effectiveness of both types of antivenom in previously reported studies on the neutralization of venom-induced local tissue damage. Both IgG and F(ab')(2) antivenoms activate human complement in vitro and induce an anti-equine immunoglobulin response in mice, indicating that Fc removal per se does not eliminate the potential for inducing adverse reactions. However, IgG antivenom had higher anticomplementary activity and induced a stronger anti-immunoglobulin response than F(ab')(2) antivenom.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137538     DOI: 10.1016/s0041-0101(00)00209-9

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  13 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.

Authors:  José María Gutiérrez; Guillermo León; Bruno Lomonte
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Study on camel IgG purification: a new approach to prepare Naja Naja Oxiana antivenom as passive immunization for therapy.

Authors:  Sedigheh Khamehchian; Hossein Zolfagharian; Naser Mohammadpour Dounighi; Majid Tebianian; Rasool Madani
Journal:  Hum Vaccin Immunother       Date:  2014-03-18       Impact factor: 3.452

3.  Anticomplementary activity of horse IgG and F(ab')2 antivenoms.

Authors:  Carla Cristina Squaiella-Baptistão; José Roberto Marcelino; Luiz Eduardo Ribeiro da Cunha; José María Gutiérrez; Denise V Tambourgi
Journal:  Am J Trop Med Hyg       Date:  2014-01-20       Impact factor: 2.345

4.  Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization.

Authors:  Somayeh Ghotloo; Mohammad Mehdi Amiri; Jalal Khoshnoodi; Ebrahim Abbasi; Mahmood Jeddi-Tehrani; Forough Golsaz-Shirazi; Fazel Shokri
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

5.  Streamlined downstream process for efficient and sustainable (Fab')2 antivenom preparation.

Authors:  Tihana Kurtović; Marija Brgles; Maja Lang Balija; Stephanie Steinberger; Dora Sviben; Martina Marchetti-Deschmann; Beata Halassy
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-07-27

6.  Quality of horse F(ab')2 antitoxins and anti-rabies immunoglobulins: protein content and anticomplementary activity.

Authors:  Carla Cristina Squaiella-Baptistão; Fábio Carlos Magnoli; José Roberto Marcelino; Osvaldo Augusto Sant'Anna; Denise V Tambourgi
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-06-18

7.  Refinement strategy for antivenom preparation of high yield and quality.

Authors:  Tihana Kurtović; Maja Lang Balija; Marija Brgles; Dora Sviben; Monika Tunjić; Hrvoje Cajner; Martina Marchetti-Deschmann; Günter Allmaier; Beata Halassy
Journal:  PLoS Negl Trop Dis       Date:  2019-06-17

Review 8.  Serotherapy against Voltage-Gated Sodium Channel-Targeting αToxins from Androctonus Scorpion Venom.

Authors:  Marie-France Martin-Eauclaire; Sonia Adi-Bessalem; Djelila Hammoudi-Triki; Fatima Laraba-Djebari; Pierre E Bougis
Journal:  Toxins (Basel)       Date:  2019-01-23       Impact factor: 4.546

Review 9.  Recent Advances in Next Generation Snakebite Antivenoms.

Authors:  Cecilie Knudsen; Andreas H Laustsen
Journal:  Trop Med Infect Dis       Date:  2018-04-15

10.  Research into the Causes of Venom-Induced Mortality and Morbidity Identifies New Therapeutic Opportunities.

Authors:  Kesturu S Girish; Gajanan D Katkar; Robert A Harrison; Kempaiah Kemparaju
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.